Researchers unlock access to verticillin A for cancer studies
EuroWire, WASHINGTON: Scientists at the Massachusetts Institute of Technology have successfully synthesised verticillin A, a complex…
Russia develops dual-action cancer drug, a game-changer in oncology
Russia pioneers theranostics with its first dual drug, improving prostate cancer diagnosis…